Fresh approach to TB vaccine offers better protection

New vaccine completely protected 41 percent of nonhuman primates; standard vaccine protected none

By Franny White January 17, 2018 Portland, Ore.

Downloads

Louis J. Picker, M.D., associate director of the OHSU Vaccine and Gene Therapy Institute and professor of pathology, molecular microbiology and immunology in the OHSU School of Medicine. (OHSU)

OHSU Picker VGTI

Louis Picker, M.D., of the Vaccine and Gene Therapy Institute at Oregon Health & Science University, June 29, 2016. (OHSU/Boone Speed Photography)